Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 27 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Urogynecology Clear all

Conditions: Satisfaction, Patient
Interventions: Virtual Visit, Office Visit; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Urogynecology
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Pelvic Organ Prolapse, Urinary Incontinence, Pelvic Floor Disorders, Gynecologic Disease, Post-Op Infection, Surgical Site Infection, Urinary Tract Infections
Interventions: Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.; Drug
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older · Female only
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Urogynecology
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 25 Years to 60 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: UTI
Interventions: 2-Way Foley Urethral Urinary Catheter; Device
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Urogynecology
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 528 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Urinary Retention, Urinary Incontinence, Pelvic Organ Prolapse, Urinary Tract Infections
Interventions: Post-void residual free voiding trial; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pelvic Floor Dysfunction, Sexual Dysfunction Female, Vibrator
Interventions: Instructional handout, Vibrator; Other · Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older · Female only
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Albany, New York

Conditions: Overactive Bladder, Overactive Bladder (OAB), Urge Urinary Incontinence, Mixed Urinary Incontinence (Urge-Predominant), Mixed Urinary Incontinence, Idiopathic Overactive Bladder With Urinary Incontinence, Idiopathic Overactive Bladder
Interventions: Detrusor nerve radiofrequency ablation, Simulated (sham) detrusor nerve radiofrequency ablation; Device
Lead sponsor: InMode MD Ltd.; Industry
Eligibility: 22 Years to 80 Years · Female only
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 9
States / cities: Palo Alto, California • Washington D.C., District of Columbia • Boise, Idaho + 6 more

Conditions: Post Operative, Post Operative Analgesia, Urogynecologic Surgery
Interventions: Tizanidine, Standard-of-Care Therapy; Drug · Other
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Post-Operative Urinary Retention
Interventions: At-home Foley Catheter Self-Removal with Passive Void Trial, In-Office Foley Catheter Removal and Backfill Void Trial; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Lebanon, New Hampshire • Manchester, New Hampshire

Conditions: Pelvic Organ Prolapse (POP), Postoperative Pain, Urogynecology
Interventions: Suzetrigine, Placebo; Drug
Lead sponsor: Aditi Talkad; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Infection Associated With Catheter, Urinary Tract Infection
Interventions: silver SPC, standard SPC; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Vaginal Laxity, Urinary Incontinence, Sexual Dysfunction
Interventions: Intragen fractional radiofrequency with NeuViVa; Device
Lead sponsor: SHERRY Thomas; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Agoura Hills, California

Conditions: Functional Disorder of Intestine
Interventions: Docusate, Bowel medications; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Overactive Bladder, Neurogenic Bladder, Urge Incontinence, Pain, Urinary Incontinence, Urinary Bladder, Overactive, Urinary Bladder, Neurogenic, Urinary Bladder Neurogenesis, Urinary Incontinence, Urge, Pelvic Floor Disorders
Interventions: Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask; Drug · Other
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Urogynecology
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 21 Years and older · Female only
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Urinary Retention, Pelvic Organ Prolapse, Stress Urinary Incontinence, Catheter Related Complication
Interventions: Catheter self-discontinuation; Procedure
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years and older · Female only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 4
States / cities: Austin, Texas • Kyle, Texas • Round Rock, Texas

Conditions: Postoperative Urinary Retention (POUR)
Interventions: Tamsulosin, Placebo; Drug
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Prolapse, Vaginal, Prolapse, Uterine, Prolapse; Female
Interventions: Educational Video, Standard Counseling; Other
Lead sponsor: TriHealth Inc.; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Cincinnati, Ohio

Conditions: Physical Activity, Surgery, Vaginal Hysterectomy, Vaginal Surgery
Interventions: Vaginal Surgery; Procedure
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older · Female only
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Postoperative Care, Urinary Catheters, Urogynecology
Interventions: Time; Other
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older · Female only
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Pelvic Organ Prolapse, Stress Urinary Incontinence, Overactive Bladder
Interventions: Pelvic organ prolapse decision aid, Stress urinary incontinence decision aid, Overactive bladder decision aid; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 95 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Virtual Visits for Postoperative Care Following Urogynecologic Surgery

Recovery After Robotic Urogynecological Surgery: The Patient's Perspective

Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures

Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers

Silver-Coated vs Standard Catheter for UTI Prevention

Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery

Reducing Postoperative Catheterization

Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

Postoperative Tizanidine Use in Pelvic Reconstructive Surgery: A Pilot Study

Self-discontinuation of Urinary Catheters in a Rural Population

Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pain Management

Uroflow Measurements in Healthy Volunteers

Silver-impregnated Suprapubic Catheters (SPC) in Urogynecology

Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.

Bowel Function After Minimally Invasive Urogynecologic Surgery

A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections

Robotic Urogynecological Surgery: Hospital Stay and Perioperative Complications

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

Impact of Preop Video on Patient Anxiety

Study Investigating Role of Unalike Patient Positioning on PROMIS Scores

Timing of Active Void Trials After Urogynecologic Procedures

Impact of Decision Aids in Urogynecology